Overview
Famotidine was introduced in mid 1970s. Famotidine is a histamine H2 receptor blocker and inhibits secretion of gastric acid produced by histamine. itused to treat and prevent duodenal and peptic ulcers, zollinger-ellison syndrome (hypersecretion of HCl) to treat gastroesophageal reflux disorder (heart burn).
Categories
No Categories Defined
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| No data regarding the Adult dosage details of is available. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of is available. |
High Risk Groups
Back to top
Warning / Precautions
Famotidine should be used with caution in patients with impaired kidney or liver function. Intravenous injection should be given slowly and intravenous infusion is recommended in patients with cardiovascular impairment.
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Back to top
Previous Drug Generic - Next Drug Generic